Evoke Pharma Inc (EVOK.OQ)
EVOK.OQ on NASDAQ Stock Exchange Capital Market
2.39USD
3:41pm BST
2.39USD
3:41pm BST
Change (% chg)
$0.05 (+2.14%)
$0.05 (+2.14%)
Prev Close
$2.34
$2.34
Open
$2.33
$2.33
Day's High
$2.39
$2.39
Day's Low
$2.33
$2.33
Volume
110
110
Avg. Vol
15,566
15,566
52-wk High
$4.09
$4.09
52-wk Low
$1.86
$1.86
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.16 | December | 25 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 5 | 5 | 5 | 5 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 18.95 |
| Year Ending Dec-19 | 5 | 32.03 | 113.20 | 0.00 | 64.37 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 4 | -0.16 | -0.09 | -0.25 | -0.20 |
| Quarter Ending Sep-18 | 4 | -0.11 | -0.05 | -0.18 | -0.18 |
| Year Ending Dec-18 | 4 | -0.56 | -0.40 | -0.84 | -0.13 |
| Year Ending Dec-19 | 5 | -0.16 | 1.85 | -0.97 | 0.55 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | ||||
| Quarter Ending Dec-17 | -0.23 | -0.02 | 0.21 | -91.38 |
| Quarter Ending Sep-17 | -0.20 | -0.34 | 0.14 | -68.32 |
| Quarter Ending Jun-17 | -0.15 | -0.11 | 0.04 | -26.67 |
| Quarter Ending Mar-17 | -0.16 | -0.15 | 0.01 | -7.69 |
| Quarter Ending Dec-16 | -0.19 | -0.12 | 0.07 | -38.14 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-18 | 0.00 | 0.00 | 0.00 | 18.95 | 18.95 |
| Year Ending Dec-19 | 32.03 | 32.03 | 35.33 | 55.75 | 64.37 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | -0.16 | -0.16 | -0.16 | -0.13 | -0.20 |
| Quarter Ending Sep-18 | -0.11 | -0.11 | -0.12 | -0.12 | -0.18 |
| Year Ending Dec-18 | -0.56 | -0.56 | -0.57 | -0.21 | -0.13 |
| Year Ending Dec-19 | -0.16 | -0.16 | -0.11 | 0.24 | 0.55 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 1 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments
- BRIEF-Evoke Pharma Q4 Loss Per Share $0.02
- BRIEF-FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application
- BRIEF-Evoke Pharma Announces Discovery Of Sex-Based Pharmacokinetic Differences For Gimoti
- BRIEF-Evoke Pharma reports Q3 loss per share $0.34